TY - JOUR
T1 - Multiple abscesses in a patient treated with cetuximab
AU - Ricci, Francesco
AU - Guerriero, Cristina
AU - Paradisi, Andrea
AU - Fossati, Barbara
AU - Micciche', Francesco
AU - Valentini, Vincenzo
AU - Capizzi, Rodolfo
PY - 2013
Y1 - 2013
N2 - Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.
AB - Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.
KW - inglese
KW - inglese
UR - http://hdl.handle.net/10807/42038
U2 - 10.1684/ejd.2012.1889
DO - 10.1684/ejd.2012.1889
M3 - Article
SN - 1167-1122
VL - 23
SP - 103
EP - 104
JO - European Journal of Dermatology
JF - European Journal of Dermatology
ER -
